To apply for the Sepracor Patient Assistance Progam, click here.

Sepracor's Patient Assistance Program is implemented and managed in collaboration with RxHope and is designed to provide prescribed Sepracor medications at no cost to those eligible patients who lack prescription drug coverage and are unable to afford them.

In order to be eligible for this program, patients:

• Must not have prescription drug coverage*;
• Must be a U.S. resident;
• Have annual income at or below 200% of U.S. Federal Poverty Level;
• Must provide proof of income; and
• Submit an application signed by both the patient and their physician.

Patients who qualify for Sepracor's Patient Assistance Program will receive a Patient Assistance Card that they can present with their prescription for a Sepracor product at a retail pharmacy. A pharmacist will dispense their medication at no cost to the patient.

This program covers all Sepracor marketed products, including: LUNESTA^® brand eszopiclone, XOPENEX^® brand levalbuterol HCl Inhalation Solution, XOPENEX HFA^® brand levalbuterol tartrate Inhalation Aerosol, and BROVANA^® brand arformoterol tartrate Inhalation Solution.

Patients interested in applying for this program should contact RxHope at 1-888-878-6266, or they may complete an online application at www.RxHope.com/Sepracor.

*If you are enrolled in Medicare Part D, you may be eligible if certain requirements are met.

Sepracor reserves the right to discontinue the Patient Assistance Program at any time, for any reason, without notice.